Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA.
Lopes RD, Granger CB, Wojdyla DM, McIntyre WF, Alings M, Mani T, Ramasundarahettige C, Rivard L, Atar D, Birnie DH, Boriani G, Amit G, Leong-Sit P, Rinne C, Duray GZ, Gold MR, Hohnloser SH, Kutyifa V, Benezet-Mazuecos J, Cosedis Nielsen J, Sticherling C, Benz AP, Linde C, Kautzner J, Mabo P, Mairesse GH, Connolly SJ, Healey JS. Lopes RD, et al. Among authors: gold mr. J Am Coll Cardiol. 2024 Jul 23;84(4):354-364. doi: 10.1016/j.jacc.2024.05.002. Epub 2024 May 19. J Am Coll Cardiol. 2024. PMID: 39019530 Clinical Trial.
Risk factors for the development of premature ventricular complex-induced cardiomyopathy: a systematic review and meta-analysis.
de Lavallaz JDF, Mézier J, Mertz L, Mannhart D, Serban T, Knecht S, Abid QU, Nguyen TT, Kühne M, Sticherling C, Huang H, Gold MR, Badertscher P. de Lavallaz JDF, et al. Among authors: gold mr. J Interv Card Electrophysiol. 2023 Aug;66(5):1145-1163. doi: 10.1007/s10840-022-01421-8. Epub 2022 Nov 21. J Interv Card Electrophysiol. 2023. PMID: 36414810 Free PMC article.
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis.
Shivakumar N, Friedman DJ, Fudim M, Abraham WT, Cleland JGF, Curtis AB, Gold MR, Kutyifa V, Linde C, Young J, Tang A, Olivas-Martinez A, Inoue LYT, Sanders GD, Al-Khatib SM. Shivakumar N, et al. Among authors: gold mr. medRxiv [Preprint]. 2023 Jul 6:2023.07.05.23292279. doi: 10.1101/2023.07.05.23292279. medRxiv. 2023. Update in: J Am Heart Assoc. 2024 Aug 6;13(15):e031785. doi: 10.1161/JAHA.123.031785 PMID: 37461448 Free PMC article. Updated. Preprint.
Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
Gold MR, El-Chami MF, Burke MC, Upadhyay GA, Niebauer MJ, Prutkin JM, Herre JM, Kutalek S, Dinerman JL, Knight BP, Leigh J, Lucas L, Carter N, Brisben AJ, Aasbo JD, Weiss R; S-ICD System Post Approval Study Investigators. Gold MR, et al. J Am Coll Cardiol. 2023 Aug 1;82(5):383-397. doi: 10.1016/j.jacc.2023.05.034. J Am Coll Cardiol. 2023. PMID: 37495274 Free article.
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation.
Healey JS, Lopes RD, Granger CB, Alings M, Rivard L, McIntyre WF, Atar D, Birnie DH, Boriani G, Camm AJ, Conen D, Erath JW, Gold MR, Hohnloser SH, Ip J, Kautzner J, Kutyifa V, Linde C, Mabo P, Mairesse G, Benezet Mazuecos J, Cosedis Nielsen J, Philippon F, Proietti M, Sticherling C, Wong JA, Wright DJ, Zarraga IG, Coutts SB, Kaplan A, Pombo M, Ayala-Paredes F, Xu L, Simek K, Nevills S, Mian R, Connolly SJ; ARTESIA Investigators. Healey JS, et al. Among authors: gold mr. N Engl J Med. 2024 Jan 11;390(2):107-117. doi: 10.1056/NEJMoa2310234. Epub 2023 Nov 12. N Engl J Med. 2024. PMID: 37952132 Clinical Trial.
Clinical outcomes of the AdaptResponse trial - Authors' reply.
Filippatos G, Gold MR, Mullens W, Kusano K, Hersi AS, Birnie D, Gerritse B, Leclercq C. Filippatos G, et al. Among authors: gold mr. Lancet. 2024 Jun 8;403(10443):2484-2485. doi: 10.1016/S0140-6736(24)00866-3. Lancet. 2024. PMID: 38851281 No abstract available.
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.
Wilkoff BL, Filippatos G, Leclercq C, Gold MR, Hersi AS, Kusano K, Mullens W, Felker GM, Kantipudi C, El-Chami MF, Essebag V, Pierre B, Philippon F, Perez-Gil F, Chung ES, Sotomonte J, Tung S, Singh B, Bozorgnia B, Goel S, Ebert HH, Varma N, Quan KJ, Salerno F, Gerritse B, van Wel J, Schaber DE, Fagan DH, Birnie D; AdaptResponse investigators. Wilkoff BL, et al. Among authors: gold mr. Lancet. 2023 Sep 30;402(10408):1147-1157. doi: 10.1016/S0140-6736(23)00912-1. Epub 2023 Aug 24. Lancet. 2023. PMID: 37634520 Clinical Trial.
Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure.
Singh JP, Rinaldi CA, Sanders P, Kubo SH, James S, Niazi IK, Betts T, Butter C, Okabe T, Cunnane R, Aziz E, Biffi M, Zaidi A, Alison J, Defaye P, Aurrichio A, Gold MR, Lindenfeld J, Rogers T, Walsh MN; SOLVE-CRT Investigators. Singh JP, et al. Among authors: gold mr. JAMA Cardiol. 2024 Oct 1;9(10):871-879. doi: 10.1001/jamacardio.2024.2050. JAMA Cardiol. 2024. PMID: 39083254 Free PMC article. Clinical Trial.
Substrate Imaging Before Catheter Ablation of Ventricular Tachycardia: Risk Prediction for Acute Hemodynamic Decompensation.
John LA, John II, Tedford RJ, Gregoski MJ, Gold MR, Field ME, Payne JE, Schoepf UJ, Suranyi P, Cochet H, Jaïs P, Santangeli P, Winterfield JR. John LA, et al. Among authors: gold mr. JACC Clin Electrophysiol. 2023 Aug;9(8 Pt 3):1684-1693. doi: 10.1016/j.jacep.2023.03.023. Epub 2023 Jun 21. JACC Clin Electrophysiol. 2023. PMID: 37354175 Free article.
591 results